Cancer immunotherapy using a membrane-bound interleukin-12 with B7-1 transmembrane and cytoplasmic domains.
about
The B7-1 cytoplasmic tail enhances intracellular transport and mammalian cell surface display of chimeric proteins in the absence of a linear ER export motif.Neoadjuvant immunotherapy with chitosan and interleukin-12 to control breast cancer metastasisTumor-infiltrating lymphocytes genetically engineered with an inducible gene encoding interleukin-12 for the immunotherapy of metastatic melanomaDevelopment of Membrane-Bound GM-CSF and IL-18 as an Effective Tumor Vaccine.Plasma membrane vesicles decorated with glycolipid-anchored antigens and adjuvants via protein transfer as an antigen delivery platform for inhibition of tumor growthInterleukin-12 Immunomodulation Delays the Onset of Lethal Peritoneal Disease of Ovarian Cancer.Expression of membrane anchored cytokines and B7-1 alters tumor microenvironment and induces protective antitumor immunity in a murine breast cancer model.Membrane-bound p35 Subunit of IL-12 on Tumor Cells is Functionally Equivalent to Membrane-bound Heterodimeric Single Chain IL-12 for Induction of Anti-tumor Immunity.Gene therapy approaches against cancer using in vivo and ex vivo gene transfer of interleukin-12.Safety and antitumor effect of oncolytic and helper-dependent adenoviruses expressing interleukin-12 variants in a hamster pancreatic cancer model.Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent.
P2860
Q35000777-4F2AEA80-BBFC-4EB5-B1E2-7747B94F5BFCQ35157433-B79BDB4F-6426-4CEC-A27F-38010FDABC98Q35613148-F4B73044-029C-402E-A895-640D522A2E0DQ35695115-A3EB9A7B-5658-4797-B9A6-3CD490014493Q36322686-D884B1E3-337F-47EA-9F19-16AA92490A29Q36489567-237F9121-E42B-46D3-8BC9-5838DC21260AQ36940633-091AFC83-8433-4F79-904D-34238286A334Q37378500-5BE0703B-75C9-4944-91D8-3F165C3F3250Q38703318-72CB266B-3E5F-4FE5-BCB4-1F0D86557604Q38879452-AFD020DB-BF04-459D-9F21-5F771BF09F2DQ45874251-22C97F76-01D3-41DF-800C-96C122C389B7
P2860
Cancer immunotherapy using a membrane-bound interleukin-12 with B7-1 transmembrane and cytoplasmic domains.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Cancer immunotherapy using a m ...... brane and cytoplasmic domains.
@ast
Cancer immunotherapy using a m ...... brane and cytoplasmic domains.
@en
type
label
Cancer immunotherapy using a m ...... brane and cytoplasmic domains.
@ast
Cancer immunotherapy using a m ...... brane and cytoplasmic domains.
@en
prefLabel
Cancer immunotherapy using a m ...... brane and cytoplasmic domains.
@ast
Cancer immunotherapy using a m ...... brane and cytoplasmic domains.
@en
P2093
P2860
P356
P1433
P1476
Cancer immunotherapy using a m ...... mbrane and cytoplasmic domains
@en
P2093
Chia-Hui Lo
Chun-Chi Chen
Mi-Hua Tao
Ping-Yi Wu
Steve R Roffler
Wen-Yu Pan
P2860
P304
P356
10.1038/MT.2012.10
P577
2012-02-14T00:00:00Z